Shopping Cart 0
Cart Subtotal
USD 0

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 8000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 12000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Lung Cancer Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 13

1.2 List of Figures 21

2 Introduction 22

2.1 Lung Cancer Diagnostic Tests Overview 22

3 Products under Development 23

3.1 Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 23

3.2 Lung Cancer Diagnostic Tests-Pipeline Products by Territory 24

3.3 Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 25

3.4 Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 26

3.5 Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 27

4 Lung Cancer Diagnostic Tests-Pipeline Products under Development by Companies 28

4.1 Lung Cancer Diagnostic Tests Companies-Pipeline Products by Stage of Development 28

4.2 Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 33

5 Lung Cancer Diagnostic Tests Companies and Product Overview 37

5.1 A&G Pharmaceutical Inc Company Overview 37

5.2 Abbott Diagnostics Company Overview 39

5.3 Abcodia Ltd Company Overview 44

5.4 Aberystwyth University Company Overview 46

5.5 Abnova Corp Company Overview 47

5.6 Acobiom Company Overview 48

5.7 Advanced Marker Discovery SL Company Overview 50

5.8 AIT Austrian Institute of Technology GmbH Company Overview 52

5.9 Almac Diagnostics Ltd Company Overview 53

5.10 ANGLE plc Company Overview 55

5.11 Armune BioScience Inc Company Overview 56

5.12 Aurelium BioPharma Inc. Company Overview 57

5.13 Avant Diagnostics, Inc. Company Overview 58

5.14 BARD1 Life Sciences Ltd Company Overview 59

5.15 BioAffinity Technologies, Inc. Company Overview 60

5.16 Biocept Inc Company Overview 61

5.17 BioChain Institute Inc Company Overview 63

5.18 Biodesix Inc Company Overview 66

5.19 Biological Dynamics, Inc. Company Overview 72

5.20 BioMark Diagnostics Inc. Company Overview 73

5.21 BioMarker Strategies LLC Company Overview 76

5.22 BioNTech AG Company Overview 78

5.23 BioSystems International Company Overview 79

5.24 Cancer Genetics Inc Company Overview 80

5.25 Cancer Research Technology Ltd Company Overview 81

5.26 Cangen Biotechnologies Inc (Inactive) Company Overview 82

5.27 CDI Laboratories Inc Company Overview 83

5.28 Celcuity LLC Company Overview 84

5.29 Cellanyx Diagnostics, Inc. Company Overview 85

5.30 CeMines, Inc. (Inactive) Company Overview 86

5.31 Cepheid Company Overview 87

5.32 Ceres Nanosciences Inc Company Overview 89

5.33 Cernostics Inc Company Overview 90

5.34 ChemImage Corp Company Overview 91

5.35 Children's Hospital Boston Company Overview 92

5.36 Clarient Inc Company Overview 93

5.37 Courtagen Life Sciences Inc Company Overview 95

5.38 Creatv MicroTech, Inc Company Overview 96

5.39 DiagnoCure Inc. (Inactive) Company Overview 97

5.40 EDP Biotech Corporation Company Overview 98

5.41 Emory University Company Overview 99

5.42 Enterome Bioscience SA Company Overview 100

5.43 Epic Sciences Inc Company Overview 101

5.44 Epigenomics AG Company Overview 102

5.45 Eventus Diagnostics Inc (Inactive) Company Overview 103

5.46 Exact Sciences Corp Company Overview 104

5.47 Exiqon A/S Company Overview 105

5.48 Exosomics Siena SpA Company Overview 106

5.49 Fahy Gurteen UK Ltd Company Overview 107

5.50 Fina Biotech SL Company Overview 108

5.51 Foundation Medicine Inc Company Overview 109

5.52 French National Institute of Health and Medical Research Company Overview 110

5.53 Fujirebio Diagnostics Inc Company Overview 111

5.54 Gene Express, Inc. (Inactive) Company Overview 112

5.55 GeneCentric Diagnostics, Inc. Company Overview 114

5.56 Global Discovery Biosciences Corporation Company Overview 115

5.57 GlycoZym Company Overview 116

5.58 Guardant Health Inc Company Overview 117

5.59 ImmunoCellular Therapeutics Ltd Company Overview 118

5.60 Insight Genetics Inc Company Overview 119

5.61 InterGenetics Inc Company Overview 122

5.62 IV Diagnostics Inc Company Overview 123

5.63 Janssen Biotech Inc Company Overview 124

5.64 Louisville Bioscience, Inc. Company Overview 125

5.65 MDNA Life Sciences Inc Company Overview 126

5.66 MDxHealth SA Company Overview 127

5.67 MEDITE Cancer Diagnostics Inc Company Overview 128

5.68 Memory Dx LLC Company Overview 129

5.69 Merrimack Pharmaceuticals Inc Company Overview 130

5.70 Metabolon Inc Company Overview 131

5.71 Metanomics Health GmbH Company Overview 132

5.72 MetaStat Inc Company Overview 133

5.73 Milagen Inc Company Overview 134

5.74 Nanocytomics LLC Company Overview 135

5.75 NEOMICS Co Ltd Company Overview 138

5.76 NovaGray Company Overview 139

5.77 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 140

5.78 Oncimmune (USA) LLC Company Overview 141

5.79 OncoCyte Corp Company Overview 142

5.80 Oncolome Diagnostics Inc (Inactive) Company Overview 146

5.81 Onconome, Inc. (Inactive) Company Overview 147

5.82 OncoStem Diagnostics Pvt. Ltd Company Overview 148

5.83 On-Q-ity, Inc. (Inactive) Company Overview 149

5.84 OPKO Health Inc Company Overview 150

5.85 Orion Genomics LLC Company Overview 151

5.86 OTraces Inc. Company Overview 152

5.87 PeriRx Inc Company Overview 153

5.88 PleX Diagnostics Inc (Inactive) Company Overview 156

5.89 Precision Biologics Inc Company Overview 157

5.90 PreMD Inc (Inactive) Company Overview 158

5.91 Proplex Technologies LLC Company Overview 159

5.92 Proteome Sciences Plc Company Overview 160

5.93 Proteomika Company Overview 161

5.94 Quest Diagnostics Inc Company Overview 162

5.95 Research Center Borstel Company Overview 163

5.96 Roche Diagnostics International Ltd Company Overview 164

5.97 Rosetta Genomics Ltd Company Overview 166

5.98 Roswell Park Cancer Institute Company Overview 167

5.99 Savicell Diagnostic Ltd. Company Overview 168

5.100 Sengenics International Pte Ltd Company Overview 169

5.101 Sienna Cancer Diagnostics Ltd Company Overview 170

5.102 Simon Fraser University Company Overview 171

5.103 Sividon Diagnostics GmbH Company Overview 172

5.104 SomaLogic Inc Company Overview 173

5.105 Southern Illinois University Carbondale Company Overview 174

5.106 Syndax Pharmaceuticals Inc Company Overview 175

5.107 Sysmex Corp Company Overview 176

5.108 The Prince Charles Hospital Company Overview 177

5.109 Thermo Fisher Scientific Inc Company Overview 178

5.110 Transgene SA Company Overview 179

5.111 Treos Bio Inc Company Overview 180

5.112 Universal Diagnostics SL Company Overview 181

5.113 University of California San Francisco Company Overview 182

5.114 University of Chicago Company Overview 183

5.115 University of Colorado Company Overview 184

5.116 University of Maryland Company Overview 185

5.117 University of Queensland Company Overview 186

5.118 University of South Florida Company Overview 187

5.119 University of Strathclyde Company Overview 188

5.120 US Biomarkers Inc Company Overview 189

5.121 Vanderbilt University Company Overview 190

5.122 Ventana Medical Systems Inc Company Overview 191

5.123 Viomics Inc. Company Overview 193

5.124 VisionGate Inc Company Overview 194

5.125 Vitatex Inc. Company Overview 195

5.126 VolitionRX Ltd Company Overview 196

5.127 Weizmann Institute of Science Company Overview 199

5.128 XEPTAGEN SpA Company Overview 200

5.129 Zetiq Technologies Ltd Company Overview 202

5.130 ZORA Biosciences Oy Company Overview 203

6 Lung Cancer Diagnostic Tests-Recent Developments 204

6.1 Jul 02, 2018: Novartis plans to spin-off eye care unit into standalone entity 204

6.2 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 204

6.3 Jul 02, 2018: Veracyte Chairman and CEO to Speak at MedCity CONVERGE 205

6.4 Jun 14, 2018: VisionGate Announces Board Change 206

6.5 Jun 13, 2018: Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals 206

6.6 Jun 12, 2018: GSK announces changes to Vaccines and Global Manufacturing & Supply leadership 207

6.7 Jun 12, 2018: OGT expands custom NGS cancer panel content 208

6.8 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 208

6.9 Jun 11, 2018: Enzo Biochem Announces Third Quarter Fiscal 2018 Financial Results 209

6.10 Jun 08, 2018: Cancer Research UK Appoints Tony Hickson As New chief business officer 212

7 Appendix 543

7.1 Methodology 543

7.2 About GlobalData 546

7.3 Contact Us 546

7.4 Disclaimer 546


List Of Figure

1.2 List of Figures

Figure 1: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 25

Figure 2: Lung Cancer Diagnostic Tests-Pipeline Products by Territory 26

Figure 3: Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 27

Figure 4: Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 28

Figure 5: Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 29


List Of Table

1.1 List of Tables

Table 1: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 25

Table 2: Lung Cancer Diagnostic Tests-Pipeline Products by Territory 26

Table 3: Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 27

Table 4: Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 28

Table 5: Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 29

Table 6: Lung Cancer Diagnostic Tests Companies-Pipeline Products by Stage of Development 30

Table 7: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 35

Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 9: Onco 88-Lung Cancer-Product Status 39

Table 10: Onco 88-Lung Cancer-Product Description 39

Table 11: OncoStain 88-Lung Cancer-Product Status 40

Table 12: OncoStain 88-Lung Cancer-Product Description 40

Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 41

Table 14: ARCHITECT c4000 System-NSE Assay-Product Status 41

Table 15: ARCHITECT c4000 System-NSE Assay-Product Description 41

Table 16: ARCHITECT c8000 System-NSE Assay-Product Status 42

Table 17: ARCHITECT c8000 System-NSE Assay-Product Description 42

Table 18: ARCHITECT ci4100 Integrated System-NSE Assay-Product Status 42

Table 19: ARCHITECT ci4100 Integrated System-NSE Assay-Product Description 43

Table 20: ARCHITECT ci8200 Integrated System-NSE Assay-Product Status 43

Table 21: ARCHITECT ci8200 Integrated System-NSE Assay-Product Description 43

Table 22: ARCHITECT i1000SR System-NSE Assay-Product Status 44

Table 23: ARCHITECT i1000SR System-NSE Assay-Product Description 44

Table 24: ARCHITECT i2000SR Integrated System-Neuron-Specific Enolase Assay-Product Status 44

Table 25: ARCHITECT i2000SR Integrated System-Neuron-Specific Enolase Assay-Product Description 45

Table 26: PRAME Antigen Lung Cancer Assay-Product Status 45

Table 27: PRAME Antigen Lung Cancer Assay-Product Description 45

Table 28: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Table 29: Diagnostic Assay-Lung Cancer-Product Status 46

Table 30: Diagnostic Assay-Lung Cancer-Product Description 46

Table 31: MCM Test-Lung Cancer-Product Status 47

Table 32: MCM Test-Lung Cancer-Product Description 47

Table 33: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 34: Diagnostic Biomarker Test-Lung Cancer-Product Status 48

Table 35: Diagnostic Biomarker Test-Lung Cancer-Product Description 48

Table 36: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview 49

Table 37: Diagnostic Test-ACTN4-Product Status 49

Table 38: Diagnostic Test-ACTN4-Product Description 49

Table 39: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 50

Table 40: Companion Diagnostic Test-Lung Cancer-Product Status 50

Table 41: Companion Diagnostic Test-Lung Cancer-Product Description 50

Table 42: Diagnostic/Prognostic Assay-Lung Cancer-Product Status 51

Table 43: Diagnostic/Prognostic Assay-Lung Cancer-Product Description 51

Table 44: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 52

Table 45: Predictive Diagnostic Test-Lung Cancer-Product Status 52

Table 46: Predictive Diagnostic Test-Lung Cancer-Product Description 52

Table 47: Prognostic Test-Lung Cancer-Product Status 53

Table 48: Prognostic Test-Lung Cancer-Product Description 53

Table 49: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 54

Table 50: Biomarker Assay-Lung Cancer-Product Status 54

Table 51: Biomarker Assay-Lung Cancer-Product Description 54

Table 52: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Table 53: Prognostic Test-Early Stage Lung Cancer-Product Status 55

Table 54: Prognostic Test-Early Stage Lung Cancer-Product Description 55

Table 55: Prognostic Test-NSCLC-Product Status 56

Table 56: Prognostic Test-NSCLC-Product Description 56

Table 57: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 57

Table 58: Parsortix-Based Test-Lung Cancer-Product Status 57

Table 59: Parsortix-Based Test-Lung Cancer-Product Description 57

Table 60: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 61: Diagnostic Test-Lung Cancer-Product Status 58

Table 62: Diagnostic Test-Lung Cancer-Product Description 58

Table 63: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 64: Lung Cancer Screening Test-Product Status 59

Table 65: Lung Cancer Screening Test-Product Description 59

Table 66: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

Table 67: TheraLink Assay-Non-Small Cell Lung Cancer-Product Status 60

Table 68: TheraLink Assay-Non-Small Cell Lung Cancer-Product Description 60

Table 69: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Table 70: BARD1 Lung Cancer Test-Product Status 61

Table 71: BARD1 Lung Cancer Test-Product Description 61

Table 72: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

Table 73: CyPath Lung-Product Status 62

Table 74: CyPath Lung-Product Description 62

Table 75: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 76: Companion Diagnostic Target Selector Test-SCLC-Product Status 63

Table 77: Companion Diagnostic Target Selector Test-SCLC-Product Description 63

Table 78: MicroRNA Test-Lung Cancer-Product Status 64

Table 79: MicroRNA Test-Lung Cancer-Product Description 64

Table 80: BioChain Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Table 81: Blood-Based Lung Cancer Test-Product Status 65

Table 82: Blood-Based Lung Cancer Test-Product Description 65

Table 83: BioChain Institute Inc-Ongoing Clinical Trials Overview 66

Table 84: Blood-Based Lung Cancer Test-Biochain Clinical Trial on Novel, Blood-based Lung Cancer Test 67

Table 85: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Table 86: PD-L1 Blood Based Diagnostic Test-Product Status 68

Table 87: PD-L1 Blood Based Diagnostic Test-Product Description 68

Table 88: TAm-Seq NGS Lung Cancer Test-Product Status 69

Table 89: TAm-Seq NGS Lung Cancer Test-Product Description 69

Table 90: VeriStrat-NSCLC-Product Status 69

Table 91: VeriStrat-NSCLC-Product Description 70

Table 92: Biodesix Inc-Ongoing Clinical Trials Overview 71

Table 93: VeriStrat-NSCLC-An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects with Non-small Cell Lung Cancer 72

Table 94: PD-L1 Blood Based Diagnostic Test-Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer 73

Table 95: Biological Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74

Table 96: OncoState Lung Assay-Product Status 74

Table 97: OncoState Lung Assay-Product Description 74

Table 98: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 75

Table 99: Metabolomics-based Diagnostic Assay-Lung Cancer-Product Status 75

Table 100: Metabolomics-based Diagnostic Assay-Lung Cancer-Product Description 75

Table 101: BioMark Diagnostics Inc.-Ongoing Clinical Trials Overview 76

Table 102: Metabolomics-based Diagnostic Assay-Lung Cancer-Clinical Trial with Patented Non-invasive, Urine-based Assay to Measure Response to Treatment for Lung Cancer 77

Table 103: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 78

Table 104: Ex Vivo Biomarker Test-Lung Cancer-Product Status 78

Table 105: Ex Vivo Biomarker Test-Lung Cancer-Product Description 78

Table 106: PathMAP NSCLC-Product Status 79

Table 107: PathMAP NSCLC-Product Description 79

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

A&;G Pharmaceutical Inc, Onco 88 - Lung Cancer; A&;G Pharmaceutical Inc, OncoStain 88 - Lung Cancer; Abbott Diagnostics, ARCHITECT c4000 System - NSE Assay; Abbott Diagnostics, ARCHITECT c8000 System - NSE Assay; Abbott Diagnostics, ARCHITECT ci4100 Integrated System - NSE Assay; Abbott Diagnostics, ARCHITECT ci8200 Integrated System - NSE Assay; Abbott Diagnostics, ARCHITECT i1000SR System - NSE Assay; Abbott Diagnostics, ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay; Abbott Diagnostics, PRAME Antigen Lung Cancer Assay; Abcodia Ltd, Diagnostic Assay - Lung Cancer; Abcodia Ltd, MCM Test - Lung Cancer; Aberystwyth University, Diagnostic Biomarker Test - Lung Cancer; Abnova Corp, Diagnostic Test - ACTN4; Acobiom, Companion Diagnostic Test - Lung Cancer; Acobiom, Diagnostic/Prognostic Assay - Lung Cancer; Advanced Marker Discovery SL, Predictive Diagnostic Test - Lung Cancer; Advanced Marker Discovery SL, Prognostic Test - Lung Cancer; AIT Austrian Institute of Technology GmbH, Biomarker Assay - Lung Cancer; Almac Diagnostics Ltd, Prognostic Test - Early Stage Lung Cancer; Almac Diagnostics Ltd, Prognostic Test - NSCLC; ANGLE plc, Parsortix-Based Test - Lung Cancer; Armune BioScience Inc, Diagnostic Test - Lung Cancer; Aurelium BioPharma Inc., Lung Cancer Screening Test; Avant Diagnostics, Inc., TheraLink Assay - Non-Small Cell Lung Cancer; BARD1 Life Sciences Ltd, BARD1 Lung Cancer Test; BioAffinity Technologies, Inc., CyPath Lung; Biocept Inc, Companion Diagnostic Target Selector Test - SCLC; Biocept Inc, MicroRNA Test - Lung Cancer; BioChain Institute Inc, Blood - Based Lung Cancer Test; Biodesix Inc, PD-L1 Blood Based Diagnostic Test; Biodesix Inc, TAm-Seq NGS Lung Cancer Test; Biodesix Inc, VeriStrat - NSCLC; Biological Dynamics, Inc., OncoState Lung Assay; BioMark Diagnostics Inc., Metabolomics-based Diagnostic Assay - Lung Cancer; BioMarker Strategies LLC, Ex Vivo Biomarker Test - Lung Cancer; BioMarker Strategies LLC, PathMAP NSCLC; BioNTech AG, Lung Cancer Screening Test; BioSystems International, QuantiPlasma Antibody Based Test - Lung Cancer; Cancer Genetics Inc, Companion Diagnostic Test - Tavocept; Cancer Research Technology Ltd, MCM Test - Lung Cancer; Cangen Biotechnologies Inc (Inactive), Diagnostic Test - Early Stage Lung Cancer; CDI Laboratories Inc, Diagnostic Test - Lung Cancer; Celcuity LLC, CELx Test - Lung Cancer; Cellanyx Diagnostics, Inc., Cellanyx Test - Lung Cancer; CeMines, Inc. (Inactive), CellCorrect LAb Test For Lung Cancer; Cepheid, Xpert Lung CA Early Detection Test; Cepheid, Xpert OncoScreen Lung Cancer Assay; Ceres Nanosciences Inc, Nanotrap Lung Cancer Biomarker Test; Cernostics Inc, TissueCypher Lung Cancer Test; ChemImage Corp, Prognostic Test - Lung Cancer; Children's Hospital Boston, Collagen XXIII Biomarker Assay - NSCLC; Clarient Inc, ALK PCR Test - NSCLC; Clarient Inc, PulmoTax; Courtagen Life Sciences Inc, Lung Cancer Diagnostic Panel; Creatv MicroTech, Inc, Diagnostic Test - Lung Cancer Recurrence; DiagnoCure Inc. (Inactive), Diagnostic Test - Lung Cancer; EDP Biotech Corporation, PulmoMarker Test; Emory University, Biomarker Assay - Small Cell Lung Cancer; Enterome Bioscience SA, IOC520; Epic Sciences Inc, PD-L1 Blood Test; Epigenomics AG, Screening And Monitoring Test - Lung Cancer; Eventus Diagnostics Inc (Inactive), Octava Test - Lung Cancer; Exact Sciences Corp, Blood-based Lung Cancer Screening Test; Exiqon A/S, miRNA Test - Lung Cancer; Exosomics Siena SpA, ExoTEST Lung; Fahy Gurteen UK Ltd, Diagnostic Test - Lung Cancer; Fina Biotech SL, Dx Bioenergetic Signature - Lung Cancer; Foundation Medicine Inc, bTMB Assay; French National Institute of Health and Medical Research, Diagnostic Assay - NSCLC Aggression; Fujirebio Diagnostics Inc, Lumipulse G - CYFRA Assay; Gene Express, Inc. (Inactive), Lung Cancer Diagnostic Assay; Gene Express, Inc. (Inactive), SCLC vs NSCLC Subclassification Diagnostic test; GeneCentric Diagnostics, Inc., Diagnostic Test - Non small Cell Lung Cancer; Global Discovery Biosciences Corporation, Aptamer-Based Blood Test - Lung Cancer; GlycoZym, Diagnostic Assay - Lung Cancer; Guardant Health Inc, Guardant360 CDx Test - Tepotinib; ImmunoCellular Therapeutics Ltd, Diagnostic Test - SCLC; Insight Genetics Inc, Insight DEPDC1 Screen Assay; Insight Genetics Inc, Insight ROS1 Fusion Screen Assay; Insight Genetics Inc, NGS Lung Panel Test; InterGenetics Inc, OncoVue Lung; IV Diagnostics Inc, Velox - Lung Cancer; Janssen Biotech Inc, Diagnostic Biomarker - Lung Cancer; Louisville Bioscience, Inc., Lung Cancer Remission pT Test; MDNA Life Sciences Inc, Lung Mitomic Test; MDxHealth SA, ConfirmMDx Lung Cancer Test; MEDITE Cancer Diagnostics Inc, Screening Assay - Lung Cancer; Memory Dx LLC, LC Sentinel Test; Merrimack Pharmaceuticals Inc, MM-121 Companion Diagnostic Assay - Non-small Cell Lung Cancer; Metabolon Inc, Diagnostic Test - Lung Cancer; Metanomics Health GmbH, Diagnostic Assay - NSCLC; MetaStat Inc, MenaCalc Lung; Milagen Inc, Immunoassay - Lung Cancer; Nanocytomics LLC, Cancer Risk Stratification Test - Lung Cancer; NEOMICS Co Ltd, AIMP2-DX2 Lung Cancer q-PCR Companion Diagnostic Test; NovaGray, NovaGray Lung Test; Novel Bio-spectrum Technologies Inc (Inactive), NBT Diagnostic Test - Lung Cancer; Oncimmune (USA) LLC, EarlyCDT - Lung Kit; OncoCyte Corp, DetermaVu; OncoCyte Corp, Lung Screening Assay; OncoCyte Corp, PanC-Dx - Lung Cancer; Oncolome Diagnostics Inc (Inactive), Lung Cancer Personalized Medicine Test; Onconome, Inc. (Inactive), Early Stage Lung Cancer Detection test; OncoStem Diagnostics Pvt. Ltd, CanAssist - Lung Cancer; On-Q-ity, Inc. (Inactive), Dual-Capture Microfluidic Chip - Lung Cancer; OPKO Health Inc, Diagnostic Test - Non-Small Cell Lung Cancer; Orion Genomics LLC, Diagnostic Test - Lung Cancer; OTraces Inc., LG Sera Dx; PeriRx Inc, SaliMark LC; PleX Diagnostics Inc (Inactive), Diagnostic Assay - Lung Cancer; Precision Biologics Inc, Diagnostic Assay - Lung Cancer; PreMD Inc (Inactive), LungAlert; Proplex Technologies Llc, Biomarker Diagnostic Test - Lung Cancer; Proteome Sciences Plc, Biomarker Panel - Lung Cancer; Proteomika, Blood-Based Diagnostic Test - Lung Cancer; Quest Diagnostics Inc, LungDx; Research Center Borstel, Diagnostic Kit - Lung Adenocarcinoma; Roche Diagnostics International Ltd, Integrated Modular Analytics - Cyfra21-1/NSE Test; Roche Diagnostics International Ltd, Integrated Modular Analytics System - NSE Test; Roche Diagnostics International Ltd, MUC1 Expression Companion Diagnostic Test; Rosetta Genomics Ltd, ROS1 Lung Cancer Biomarker Assay; Roswell Park Cancer Institute, Blood-Based Diagnostic Test - Lung Cancer; Savicell Diagnostic Ltd., Screening Test - Lung Cancer; Sengenics International Pte Ltd, Diagnostic Assay - Lung Cancer; Sienna Cancer Diagnostics Ltd, Sienna Test - Lung Cancer; Simon Fraser University, DORS Based Diagnostic Device - Non-small Cell Lung Cancer; Sividon Diagnostics GmbH, Diagnostic Assay - Lung Cancer; SomaLogic Inc, SOMAScan Assay - Lung Cancer; Southern Illinois University Carbondale, Diagnostic Test - Lung Cancer; Syndax Pharmaceuticals Inc, Entinostat Companion Diagnostic Assay; Sysmex Corp, Immunochemistry Test - CK19F; The Prince Charles Hospital, Diagnostic Test - Lung Cancer; Thermo Fisher Scientific Inc, Oncomine Dx Target Test - BLU-667; Transgene SA, aNK Test; Treos Bio Inc, PolyPEPI 814 CDx; Universal Diagnostics SL, Blood-Based Diagnostic Test - Lung Cancer; University of California San Francisco, Companion Diagnostic Test - Lung Cancer; University of Chicago, Paxillin Prognostic Biomarker - Lung Cancer; University of Colorado, MicroRNA Assay - Non-small Cell Lung Cancer; University of Maryland, Biomarker Blood Test - NSCLC; University of Queensland, Biomarker Test - Lung Cancer; University of South Florida, Biomarker Test - Lung Cancer; University of Strathclyde, RNA-Nanoprobe - Lung Cancer; US Biomarkers Inc, Blood-Based Biomarker - Lung Cancer; Vanderbilt University, Companion Diagnostic Assay - Small-Cell Lung Cancer; Ventana Medical Systems Inc, OptiView ALK (D5F3); Ventana Medical Systems Inc, PD-L1 Companion Diagnostics Assay; Viomics Inc., LungVantage Test; VisionGate Inc, LuCED Lung Test; Vitatex Inc., Lung Cancer CTC Detection Kit; VolitionRX Ltd, NuQ Diagnostic Test - Lung Cancer; Weizmann Institute of Science, Diagnostic Test - Lung Cancer; XEPTAGEN SpA, SCCA - IgM Kit - NASH; XEPTAGEN SpA, VEGF - IgM Kit - Pulmonary Cancer; Zetiq Technologies Ltd, CellDetect - Lung Cancer; ZORA Biosciences Oy, Lipidomic Marker Test - Lung Cancer


Companies

A&G Pharmaceutical Inc

Abbott Diagnostics

Abcodia Ltd

Aberystwyth University

Abnova Corp

Acobiom

Advanced Marker Discovery SL

AIT Austrian Institute of Technology GmbH

Almac Diagnostics Ltd

ANGLE plc

Armune BioScience Inc

Aurelium BioPharma Inc.

Avant Diagnostics, Inc.

BARD1 Life Sciences Ltd

BioAffinity Technologies, Inc.

Biocept Inc

BioChain Institute Inc

Biodesix Inc

Biological Dynamics, Inc.

BioMark Diagnostics Inc.

BioMarker Strategies LLC

BioNTech AG

BioSystems International

Cancer Genetics Inc

Cancer Research Technology Ltd

Cangen Biotechnologies Inc

CDI Laboratories Inc

Celcuity LLC

Cellanyx Diagnostics, Inc.

CeMines, Inc.

Cepheid

Ceres Nanosciences Inc

Cernostics Inc

ChemImage Corp

Children's Hospital Boston

Clarient Inc

Courtagen Life Sciences Inc

Creatv MicroTech, Inc

DiagnoCure Inc.

EDP Biotech Corporation

Emory University

Enterome Bioscience SA

Epic Sciences Inc

Epigenomics AG

Eventus Diagnostics Inc

Exact Sciences Corp

Exiqon A/S

Exosomics Siena SpA

Fahy Gurteen UK Ltd

Fina Biotech SL

Foundation Medicine Inc

French National Institute of Health and Medical Research

Fujirebio Diagnostics Inc

Gene Express, Inc.

GeneCentric Diagnostics, Inc.

Global Discovery Biosciences Corporation

GlycoZym

Guardant Health Inc

ImmunoCellular Therapeutics Ltd

Insight Genetics Inc

InterGenetics Inc

IV Diagnostics Inc

Janssen Biotech Inc

Louisville Bioscience, Inc.

MDNA Life Sciences Inc

MDxHealth SA

MEDITE Cancer Diagnostics Inc

Memory Dx LLC

Merrimack Pharmaceuticals Inc

Metabolon Inc

Metanomics Health GmbH

MetaStat Inc

Milagen Inc

Nanocytomics LLC

NEOMICS Co Ltd

NovaGray

Novel Bio-spectrum Technologies Inc

Oncimmune (USA) LLC

OncoCyte Corp

Oncolome Diagnostics Inc

Onconome, Inc.

OncoStem Diagnostics Pvt. Ltd

On-Q-ity, Inc.

OPKO Health Inc

Orion Genomics LLC

OTraces Inc.

PeriRx Inc

PleX Diagnostics Inc

Precision Biologics Inc

PreMD Inc

Proplex Technologies LLC

Proteome Sciences Plc

Proteomika

Quest Diagnostics Inc

Research Center Borstel

Roche Diagnostics International Ltd

Rosetta Genomics Ltd

Roswell Park Cancer Institute

Savicell Diagnostic Ltd.

Sengenics International Pte Ltd

Sienna Cancer Diagnostics Ltd

Simon Fraser University

Sividon Diagnostics GmbH

SomaLogic Inc

Southern Illinois University Carbondale

Syndax Pharmaceuticals Inc

Sysmex Corp

The Prince Charles Hospital

Thermo Fisher Scientific Inc

Transgene SA

Treos Bio Inc

Universal Diagnostics SL

University of California San Francisco

University of Chicago

University of Colorado

University of Maryland

University of Queensland

University of South Florida

University of Strathclyde

US Biomarkers Inc

Vanderbilt University

Ventana Medical Systems Inc

Viomics Inc.

VisionGate Inc

Vitatex Inc.

VolitionRX Ltd

Weizmann Institute of Science

XEPTAGEN SpA

Zetiq Technologies Ltd

ZORA Biosciences Oy

Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2018" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Lung Cancer Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 13

1.2 List of Figures 21

2 Introduction 22

2.1 Lung Cancer Diagnostic Tests Overview 22

3 Products under Development 23

3.1 Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 23

3.2 Lung Cancer Diagnostic Tests-Pipeline Products by Territory 24

3.3 Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 25

3.4 Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 26

3.5 Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 27

4 Lung Cancer Diagnostic Tests-Pipeline Products under Development by Companies 28

4.1 Lung Cancer Diagnostic Tests Companies-Pipeline Products by Stage of Development 28

4.2 Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 33

5 Lung Cancer Diagnostic Tests Companies and Product Overview 37

5.1 A&G Pharmaceutical Inc Company Overview 37

5.2 Abbott Diagnostics Company Overview 39

5.3 Abcodia Ltd Company Overview 44

5.4 Aberystwyth University Company Overview 46

5.5 Abnova Corp Company Overview 47

5.6 Acobiom Company Overview 48

5.7 Advanced Marker Discovery SL Company Overview 50

5.8 AIT Austrian Institute of Technology GmbH Company Overview 52

5.9 Almac Diagnostics Ltd Company Overview 53

5.10 ANGLE plc Company Overview 55

5.11 Armune BioScience Inc Company Overview 56

5.12 Aurelium BioPharma Inc. Company Overview 57

5.13 Avant Diagnostics, Inc. Company Overview 58

5.14 BARD1 Life Sciences Ltd Company Overview 59

5.15 BioAffinity Technologies, Inc. Company Overview 60

5.16 Biocept Inc Company Overview 61

5.17 BioChain Institute Inc Company Overview 63

5.18 Biodesix Inc Company Overview 66

5.19 Biological Dynamics, Inc. Company Overview 72

5.20 BioMark Diagnostics Inc. Company Overview 73

5.21 BioMarker Strategies LLC Company Overview 76

5.22 BioNTech AG Company Overview 78

5.23 BioSystems International Company Overview 79

5.24 Cancer Genetics Inc Company Overview 80

5.25 Cancer Research Technology Ltd Company Overview 81

5.26 Cangen Biotechnologies Inc (Inactive) Company Overview 82

5.27 CDI Laboratories Inc Company Overview 83

5.28 Celcuity LLC Company Overview 84

5.29 Cellanyx Diagnostics, Inc. Company Overview 85

5.30 CeMines, Inc. (Inactive) Company Overview 86

5.31 Cepheid Company Overview 87

5.32 Ceres Nanosciences Inc Company Overview 89

5.33 Cernostics Inc Company Overview 90

5.34 ChemImage Corp Company Overview 91

5.35 Children's Hospital Boston Company Overview 92

5.36 Clarient Inc Company Overview 93

5.37 Courtagen Life Sciences Inc Company Overview 95

5.38 Creatv MicroTech, Inc Company Overview 96

5.39 DiagnoCure Inc. (Inactive) Company Overview 97

5.40 EDP Biotech Corporation Company Overview 98

5.41 Emory University Company Overview 99

5.42 Enterome Bioscience SA Company Overview 100

5.43 Epic Sciences Inc Company Overview 101

5.44 Epigenomics AG Company Overview 102

5.45 Eventus Diagnostics Inc (Inactive) Company Overview 103

5.46 Exact Sciences Corp Company Overview 104

5.47 Exiqon A/S Company Overview 105

5.48 Exosomics Siena SpA Company Overview 106

5.49 Fahy Gurteen UK Ltd Company Overview 107

5.50 Fina Biotech SL Company Overview 108

5.51 Foundation Medicine Inc Company Overview 109

5.52 French National Institute of Health and Medical Research Company Overview 110

5.53 Fujirebio Diagnostics Inc Company Overview 111

5.54 Gene Express, Inc. (Inactive) Company Overview 112

5.55 GeneCentric Diagnostics, Inc. Company Overview 114

5.56 Global Discovery Biosciences Corporation Company Overview 115

5.57 GlycoZym Company Overview 116

5.58 Guardant Health Inc Company Overview 117

5.59 ImmunoCellular Therapeutics Ltd Company Overview 118

5.60 Insight Genetics Inc Company Overview 119

5.61 InterGenetics Inc Company Overview 122

5.62 IV Diagnostics Inc Company Overview 123

5.63 Janssen Biotech Inc Company Overview 124

5.64 Louisville Bioscience, Inc. Company Overview 125

5.65 MDNA Life Sciences Inc Company Overview 126

5.66 MDxHealth SA Company Overview 127

5.67 MEDITE Cancer Diagnostics Inc Company Overview 128

5.68 Memory Dx LLC Company Overview 129

5.69 Merrimack Pharmaceuticals Inc Company Overview 130

5.70 Metabolon Inc Company Overview 131

5.71 Metanomics Health GmbH Company Overview 132

5.72 MetaStat Inc Company Overview 133

5.73 Milagen Inc Company Overview 134

5.74 Nanocytomics LLC Company Overview 135

5.75 NEOMICS Co Ltd Company Overview 138

5.76 NovaGray Company Overview 139

5.77 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview 140

5.78 Oncimmune (USA) LLC Company Overview 141

5.79 OncoCyte Corp Company Overview 142

5.80 Oncolome Diagnostics Inc (Inactive) Company Overview 146

5.81 Onconome, Inc. (Inactive) Company Overview 147

5.82 OncoStem Diagnostics Pvt. Ltd Company Overview 148

5.83 On-Q-ity, Inc. (Inactive) Company Overview 149

5.84 OPKO Health Inc Company Overview 150

5.85 Orion Genomics LLC Company Overview 151

5.86 OTraces Inc. Company Overview 152

5.87 PeriRx Inc Company Overview 153

5.88 PleX Diagnostics Inc (Inactive) Company Overview 156

5.89 Precision Biologics Inc Company Overview 157

5.90 PreMD Inc (Inactive) Company Overview 158

5.91 Proplex Technologies LLC Company Overview 159

5.92 Proteome Sciences Plc Company Overview 160

5.93 Proteomika Company Overview 161

5.94 Quest Diagnostics Inc Company Overview 162

5.95 Research Center Borstel Company Overview 163

5.96 Roche Diagnostics International Ltd Company Overview 164

5.97 Rosetta Genomics Ltd Company Overview 166

5.98 Roswell Park Cancer Institute Company Overview 167

5.99 Savicell Diagnostic Ltd. Company Overview 168

5.100 Sengenics International Pte Ltd Company Overview 169

5.101 Sienna Cancer Diagnostics Ltd Company Overview 170

5.102 Simon Fraser University Company Overview 171

5.103 Sividon Diagnostics GmbH Company Overview 172

5.104 SomaLogic Inc Company Overview 173

5.105 Southern Illinois University Carbondale Company Overview 174

5.106 Syndax Pharmaceuticals Inc Company Overview 175

5.107 Sysmex Corp Company Overview 176

5.108 The Prince Charles Hospital Company Overview 177

5.109 Thermo Fisher Scientific Inc Company Overview 178

5.110 Transgene SA Company Overview 179

5.111 Treos Bio Inc Company Overview 180

5.112 Universal Diagnostics SL Company Overview 181

5.113 University of California San Francisco Company Overview 182

5.114 University of Chicago Company Overview 183

5.115 University of Colorado Company Overview 184

5.116 University of Maryland Company Overview 185

5.117 University of Queensland Company Overview 186

5.118 University of South Florida Company Overview 187

5.119 University of Strathclyde Company Overview 188

5.120 US Biomarkers Inc Company Overview 189

5.121 Vanderbilt University Company Overview 190

5.122 Ventana Medical Systems Inc Company Overview 191

5.123 Viomics Inc. Company Overview 193

5.124 VisionGate Inc Company Overview 194

5.125 Vitatex Inc. Company Overview 195

5.126 VolitionRX Ltd Company Overview 196

5.127 Weizmann Institute of Science Company Overview 199

5.128 XEPTAGEN SpA Company Overview 200

5.129 Zetiq Technologies Ltd Company Overview 202

5.130 ZORA Biosciences Oy Company Overview 203

6 Lung Cancer Diagnostic Tests-Recent Developments 204

6.1 Jul 02, 2018: Novartis plans to spin-off eye care unit into standalone entity 204

6.2 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein 204

6.3 Jul 02, 2018: Veracyte Chairman and CEO to Speak at MedCity CONVERGE 205

6.4 Jun 14, 2018: VisionGate Announces Board Change 206

6.5 Jun 13, 2018: Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals 206

6.6 Jun 12, 2018: GSK announces changes to Vaccines and Global Manufacturing & Supply leadership 207

6.7 Jun 12, 2018: OGT expands custom NGS cancer panel content 208

6.8 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 208

6.9 Jun 11, 2018: Enzo Biochem Announces Third Quarter Fiscal 2018 Financial Results 209

6.10 Jun 08, 2018: Cancer Research UK Appoints Tony Hickson As New chief business officer 212

7 Appendix 543

7.1 Methodology 543

7.2 About GlobalData 546

7.3 Contact Us 546

7.4 Disclaimer 546


List Of Figure

1.2 List of Figures

Figure 1: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 25

Figure 2: Lung Cancer Diagnostic Tests-Pipeline Products by Territory 26

Figure 3: Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 27

Figure 4: Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 28

Figure 5: Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 29


List Of Table

1.1 List of Tables

Table 1: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 25

Table 2: Lung Cancer Diagnostic Tests-Pipeline Products by Territory 26

Table 3: Lung Cancer Diagnostic Tests-Pipeline Products by Regulatory Path 27

Table 4: Lung Cancer Diagnostic Tests-Pipeline Products by Estimated Approval Date 28

Table 5: Lung Cancer Diagnostic Tests-Ongoing Clinical Trials 29

Table 6: Lung Cancer Diagnostic Tests Companies-Pipeline Products by Stage of Development 30

Table 7: Lung Cancer Diagnostic Tests-Pipeline Products by Stage of Development 35

Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 9: Onco 88-Lung Cancer-Product Status 39

Table 10: Onco 88-Lung Cancer-Product Description 39

Table 11: OncoStain 88-Lung Cancer-Product Status 40

Table 12: OncoStain 88-Lung Cancer-Product Description 40

Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 41

Table 14: ARCHITECT c4000 System-NSE Assay-Product Status 41

Table 15: ARCHITECT c4000 System-NSE Assay-Product Description 41

Table 16: ARCHITECT c8000 System-NSE Assay-Product Status 42

Table 17: ARCHITECT c8000 System-NSE Assay-Product Description 42

Table 18: ARCHITECT ci4100 Integrated System-NSE Assay-Product Status 42

Table 19: ARCHITECT ci4100 Integrated System-NSE Assay-Product Description 43

Table 20: ARCHITECT ci8200 Integrated System-NSE Assay-Product Status 43

Table 21: ARCHITECT ci8200 Integrated System-NSE Assay-Product Description 43

Table 22: ARCHITECT i1000SR System-NSE Assay-Product Status 44

Table 23: ARCHITECT i1000SR System-NSE Assay-Product Description 44

Table 24: ARCHITECT i2000SR Integrated System-Neuron-Specific Enolase Assay-Product Status 44

Table 25: ARCHITECT i2000SR Integrated System-Neuron-Specific Enolase Assay-Product Description 45

Table 26: PRAME Antigen Lung Cancer Assay-Product Status 45

Table 27: PRAME Antigen Lung Cancer Assay-Product Description 45

Table 28: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Table 29: Diagnostic Assay-Lung Cancer-Product Status 46

Table 30: Diagnostic Assay-Lung Cancer-Product Description 46

Table 31: MCM Test-Lung Cancer-Product Status 47

Table 32: MCM Test-Lung Cancer-Product Description 47

Table 33: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview 48

Table 34: Diagnostic Biomarker Test-Lung Cancer-Product Status 48

Table 35: Diagnostic Biomarker Test-Lung Cancer-Product Description 48

Table 36: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview 49

Table 37: Diagnostic Test-ACTN4-Product Status 49

Table 38: Diagnostic Test-ACTN4-Product Description 49

Table 39: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 50

Table 40: Companion Diagnostic Test-Lung Cancer-Product Status 50

Table 41: Companion Diagnostic Test-Lung Cancer-Product Description 50

Table 42: Diagnostic/Prognostic Assay-Lung Cancer-Product Status 51

Table 43: Diagnostic/Prognostic Assay-Lung Cancer-Product Description 51

Table 44: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 52

Table 45: Predictive Diagnostic Test-Lung Cancer-Product Status 52

Table 46: Predictive Diagnostic Test-Lung Cancer-Product Description 52

Table 47: Prognostic Test-Lung Cancer-Product Status 53

Table 48: Prognostic Test-Lung Cancer-Product Description 53

Table 49: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 54

Table 50: Biomarker Assay-Lung Cancer-Product Status 54

Table 51: Biomarker Assay-Lung Cancer-Product Description 54

Table 52: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Table 53: Prognostic Test-Early Stage Lung Cancer-Product Status 55

Table 54: Prognostic Test-Early Stage Lung Cancer-Product Description 55

Table 55: Prognostic Test-NSCLC-Product Status 56

Table 56: Prognostic Test-NSCLC-Product Description 56

Table 57: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview 57

Table 58: Parsortix-Based Test-Lung Cancer-Product Status 57

Table 59: Parsortix-Based Test-Lung Cancer-Product Description 57

Table 60: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 61: Diagnostic Test-Lung Cancer-Product Status 58

Table 62: Diagnostic Test-Lung Cancer-Product Description 58

Table 63: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 64: Lung Cancer Screening Test-Product Status 59

Table 65: Lung Cancer Screening Test-Product Description 59

Table 66: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

Table 67: TheraLink Assay-Non-Small Cell Lung Cancer-Product Status 60

Table 68: TheraLink Assay-Non-Small Cell Lung Cancer-Product Description 60

Table 69: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Table 70: BARD1 Lung Cancer Test-Product Status 61

Table 71: BARD1 Lung Cancer Test-Product Description 61

Table 72: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62

Table 73: CyPath Lung-Product Status 62

Table 74: CyPath Lung-Product Description 62

Table 75: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 76: Companion Diagnostic Target Selector Test-SCLC-Product Status 63

Table 77: Companion Diagnostic Target Selector Test-SCLC-Product Description 63

Table 78: MicroRNA Test-Lung Cancer-Product Status 64

Table 79: MicroRNA Test-Lung Cancer-Product Description 64

Table 80: BioChain Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Table 81: Blood-Based Lung Cancer Test-Product Status 65

Table 82: Blood-Based Lung Cancer Test-Product Description 65

Table 83: BioChain Institute Inc-Ongoing Clinical Trials Overview 66

Table 84: Blood-Based Lung Cancer Test-Biochain Clinical Trial on Novel, Blood-based Lung Cancer Test 67

Table 85: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Table 86: PD-L1 Blood Based Diagnostic Test-Product Status 68

Table 87: PD-L1 Blood Based Diagnostic Test-Product Description 68

Table 88: TAm-Seq NGS Lung Cancer Test-Product Status 69

Table 89: TAm-Seq NGS Lung Cancer Test-Product Description 69

Table 90: VeriStrat-NSCLC-Product Status 69

Table 91: VeriStrat-NSCLC-Product Description 70

Table 92: Biodesix Inc-Ongoing Clinical Trials Overview 71

Table 93: VeriStrat-NSCLC-An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects with Non-small Cell Lung Cancer 72

Table 94: PD-L1 Blood Based Diagnostic Test-Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer 73

Table 95: Biological Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74

Table 96: OncoState Lung Assay-Product Status 74

Table 97: OncoState Lung Assay-Product Description 74

Table 98: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 75

Table 99: Metabolomics-based Diagnostic Assay-Lung Cancer-Product Status 75

Table 100: Metabolomics-based Diagnostic Assay-Lung Cancer-Product Description 75

Table 101: BioMark Diagnostics Inc.-Ongoing Clinical Trials Overview 76

Table 102: Metabolomics-based Diagnostic Assay-Lung Cancer-Clinical Trial with Patented Non-invasive, Urine-based Assay to Measure Response to Treatment for Lung Cancer 77

Table 103: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 78

Table 104: Ex Vivo Biomarker Test-Lung Cancer-Product Status 78

Table 105: Ex Vivo Biomarker Test-Lung Cancer-Product Description 78

Table 106: PathMAP NSCLC-Product Status 79

Table 107: PathMAP NSCLC-Product Description 79

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

A&;G Pharmaceutical Inc, Onco 88 - Lung Cancer; A&;G Pharmaceutical Inc, OncoStain 88 - Lung Cancer; Abbott Diagnostics, ARCHITECT c4000 System - NSE Assay; Abbott Diagnostics, ARCHITECT c8000 System - NSE Assay; Abbott Diagnostics, ARCHITECT ci4100 Integrated System - NSE Assay; Abbott Diagnostics, ARCHITECT ci8200 Integrated System - NSE Assay; Abbott Diagnostics, ARCHITECT i1000SR System - NSE Assay; Abbott Diagnostics, ARCHITECT i2000SR Integrated System - Neuron-Specific Enolase Assay; Abbott Diagnostics, PRAME Antigen Lung Cancer Assay; Abcodia Ltd, Diagnostic Assay - Lung Cancer; Abcodia Ltd, MCM Test - Lung Cancer; Aberystwyth University, Diagnostic Biomarker Test - Lung Cancer; Abnova Corp, Diagnostic Test - ACTN4; Acobiom, Companion Diagnostic Test - Lung Cancer; Acobiom, Diagnostic/Prognostic Assay - Lung Cancer; Advanced Marker Discovery SL, Predictive Diagnostic Test - Lung Cancer; Advanced Marker Discovery SL, Prognostic Test - Lung Cancer; AIT Austrian Institute of Technology GmbH, Biomarker Assay - Lung Cancer; Almac Diagnostics Ltd, Prognostic Test - Early Stage Lung Cancer; Almac Diagnostics Ltd, Prognostic Test - NSCLC; ANGLE plc, Parsortix-Based Test - Lung Cancer; Armune BioScience Inc, Diagnostic Test - Lung Cancer; Aurelium BioPharma Inc., Lung Cancer Screening Test; Avant Diagnostics, Inc., TheraLink Assay - Non-Small Cell Lung Cancer; BARD1 Life Sciences Ltd, BARD1 Lung Cancer Test; BioAffinity Technologies, Inc., CyPath Lung; Biocept Inc, Companion Diagnostic Target Selector Test - SCLC; Biocept Inc, MicroRNA Test - Lung Cancer; BioChain Institute Inc, Blood - Based Lung Cancer Test; Biodesix Inc, PD-L1 Blood Based Diagnostic Test; Biodesix Inc, TAm-Seq NGS Lung Cancer Test; Biodesix Inc, VeriStrat - NSCLC; Biological Dynamics, Inc., OncoState Lung Assay; BioMark Diagnostics Inc., Metabolomics-based Diagnostic Assay - Lung Cancer; BioMarker Strategies LLC, Ex Vivo Biomarker Test - Lung Cancer; BioMarker Strategies LLC, PathMAP NSCLC; BioNTech AG, Lung Cancer Screening Test; BioSystems International, QuantiPlasma Antibody Based Test - Lung Cancer; Cancer Genetics Inc, Companion Diagnostic Test - Tavocept; Cancer Research Technology Ltd, MCM Test - Lung Cancer; Cangen Biotechnologies Inc (Inactive), Diagnostic Test - Early Stage Lung Cancer; CDI Laboratories Inc, Diagnostic Test - Lung Cancer; Celcuity LLC, CELx Test - Lung Cancer; Cellanyx Diagnostics, Inc., Cellanyx Test - Lung Cancer; CeMines, Inc. (Inactive), CellCorrect LAb Test For Lung Cancer; Cepheid, Xpert Lung CA Early Detection Test; Cepheid, Xpert OncoScreen Lung Cancer Assay; Ceres Nanosciences Inc, Nanotrap Lung Cancer Biomarker Test; Cernostics Inc, TissueCypher Lung Cancer Test; ChemImage Corp, Prognostic Test - Lung Cancer; Children's Hospital Boston, Collagen XXIII Biomarker Assay - NSCLC; Clarient Inc, ALK PCR Test - NSCLC; Clarient Inc, PulmoTax; Courtagen Life Sciences Inc, Lung Cancer Diagnostic Panel; Creatv MicroTech, Inc, Diagnostic Test - Lung Cancer Recurrence; DiagnoCure Inc. (Inactive), Diagnostic Test - Lung Cancer; EDP Biotech Corporation, PulmoMarker Test; Emory University, Biomarker Assay - Small Cell Lung Cancer; Enterome Bioscience SA, IOC520; Epic Sciences Inc, PD-L1 Blood Test; Epigenomics AG, Screening And Monitoring Test - Lung Cancer; Eventus Diagnostics Inc (Inactive), Octava Test - Lung Cancer; Exact Sciences Corp, Blood-based Lung Cancer Screening Test; Exiqon A/S, miRNA Test - Lung Cancer; Exosomics Siena SpA, ExoTEST Lung; Fahy Gurteen UK Ltd, Diagnostic Test - Lung Cancer; Fina Biotech SL, Dx Bioenergetic Signature - Lung Cancer; Foundation Medicine Inc, bTMB Assay; French National Institute of Health and Medical Research, Diagnostic Assay - NSCLC Aggression; Fujirebio Diagnostics Inc, Lumipulse G - CYFRA Assay; Gene Express, Inc. (Inactive), Lung Cancer Diagnostic Assay; Gene Express, Inc. (Inactive), SCLC vs NSCLC Subclassification Diagnostic test; GeneCentric Diagnostics, Inc., Diagnostic Test - Non small Cell Lung Cancer; Global Discovery Biosciences Corporation, Aptamer-Based Blood Test - Lung Cancer; GlycoZym, Diagnostic Assay - Lung Cancer; Guardant Health Inc, Guardant360 CDx Test - Tepotinib; ImmunoCellular Therapeutics Ltd, Diagnostic Test - SCLC; Insight Genetics Inc, Insight DEPDC1 Screen Assay; Insight Genetics Inc, Insight ROS1 Fusion Screen Assay; Insight Genetics Inc, NGS Lung Panel Test; InterGenetics Inc, OncoVue Lung; IV Diagnostics Inc, Velox - Lung Cancer; Janssen Biotech Inc, Diagnostic Biomarker - Lung Cancer; Louisville Bioscience, Inc., Lung Cancer Remission pT Test; MDNA Life Sciences Inc, Lung Mitomic Test; MDxHealth SA, ConfirmMDx Lung Cancer Test; MEDITE Cancer Diagnostics Inc, Screening Assay - Lung Cancer; Memory Dx LLC, LC Sentinel Test; Merrimack Pharmaceuticals Inc, MM-121 Companion Diagnostic Assay - Non-small Cell Lung Cancer; Metabolon Inc, Diagnostic Test - Lung Cancer; Metanomics Health GmbH, Diagnostic Assay - NSCLC; MetaStat Inc, MenaCalc Lung; Milagen Inc, Immunoassay - Lung Cancer; Nanocytomics LLC, Cancer Risk Stratification Test - Lung Cancer; NEOMICS Co Ltd, AIMP2-DX2 Lung Cancer q-PCR Companion Diagnostic Test; NovaGray, NovaGray Lung Test; Novel Bio-spectrum Technologies Inc (Inactive), NBT Diagnostic Test - Lung Cancer; Oncimmune (USA) LLC, EarlyCDT - Lung Kit; OncoCyte Corp, DetermaVu; OncoCyte Corp, Lung Screening Assay; OncoCyte Corp, PanC-Dx - Lung Cancer; Oncolome Diagnostics Inc (Inactive), Lung Cancer Personalized Medicine Test; Onconome, Inc. (Inactive), Early Stage Lung Cancer Detection test; OncoStem Diagnostics Pvt. Ltd, CanAssist - Lung Cancer; On-Q-ity, Inc. (Inactive), Dual-Capture Microfluidic Chip - Lung Cancer; OPKO Health Inc, Diagnostic Test - Non-Small Cell Lung Cancer; Orion Genomics LLC, Diagnostic Test - Lung Cancer; OTraces Inc., LG Sera Dx; PeriRx Inc, SaliMark LC; PleX Diagnostics Inc (Inactive), Diagnostic Assay - Lung Cancer; Precision Biologics Inc, Diagnostic Assay - Lung Cancer; PreMD Inc (Inactive), LungAlert; Proplex Technologies Llc, Biomarker Diagnostic Test - Lung Cancer; Proteome Sciences Plc, Biomarker Panel - Lung Cancer; Proteomika, Blood-Based Diagnostic Test - Lung Cancer; Quest Diagnostics Inc, LungDx; Research Center Borstel, Diagnostic Kit - Lung Adenocarcinoma; Roche Diagnostics International Ltd, Integrated Modular Analytics - Cyfra21-1/NSE Test; Roche Diagnostics International Ltd, Integrated Modular Analytics System - NSE Test; Roche Diagnostics International Ltd, MUC1 Expression Companion Diagnostic Test; Rosetta Genomics Ltd, ROS1 Lung Cancer Biomarker Assay; Roswell Park Cancer Institute, Blood-Based Diagnostic Test - Lung Cancer; Savicell Diagnostic Ltd., Screening Test - Lung Cancer; Sengenics International Pte Ltd, Diagnostic Assay - Lung Cancer; Sienna Cancer Diagnostics Ltd, Sienna Test - Lung Cancer; Simon Fraser University, DORS Based Diagnostic Device - Non-small Cell Lung Cancer; Sividon Diagnostics GmbH, Diagnostic Assay - Lung Cancer; SomaLogic Inc, SOMAScan Assay - Lung Cancer; Southern Illinois University Carbondale, Diagnostic Test - Lung Cancer; Syndax Pharmaceuticals Inc, Entinostat Companion Diagnostic Assay; Sysmex Corp, Immunochemistry Test - CK19F; The Prince Charles Hospital, Diagnostic Test - Lung Cancer; Thermo Fisher Scientific Inc, Oncomine Dx Target Test - BLU-667; Transgene SA, aNK Test; Treos Bio Inc, PolyPEPI 814 CDx; Universal Diagnostics SL, Blood-Based Diagnostic Test - Lung Cancer; University of California San Francisco, Companion Diagnostic Test - Lung Cancer; University of Chicago, Paxillin Prognostic Biomarker - Lung Cancer; University of Colorado, MicroRNA Assay - Non-small Cell Lung Cancer; University of Maryland, Biomarker Blood Test - NSCLC; University of Queensland, Biomarker Test - Lung Cancer; University of South Florida, Biomarker Test - Lung Cancer; University of Strathclyde, RNA-Nanoprobe - Lung Cancer; US Biomarkers Inc, Blood-Based Biomarker - Lung Cancer; Vanderbilt University, Companion Diagnostic Assay - Small-Cell Lung Cancer; Ventana Medical Systems Inc, OptiView ALK (D5F3); Ventana Medical Systems Inc, PD-L1 Companion Diagnostics Assay; Viomics Inc., LungVantage Test; VisionGate Inc, LuCED Lung Test; Vitatex Inc., Lung Cancer CTC Detection Kit; VolitionRX Ltd, NuQ Diagnostic Test - Lung Cancer; Weizmann Institute of Science, Diagnostic Test - Lung Cancer; XEPTAGEN SpA, SCCA - IgM Kit - NASH; XEPTAGEN SpA, VEGF - IgM Kit - Pulmonary Cancer; Zetiq Technologies Ltd, CellDetect - Lung Cancer; ZORA Biosciences Oy, Lipidomic Marker Test - Lung Cancer


Companies

A&G Pharmaceutical Inc

Abbott Diagnostics

Abcodia Ltd

Aberystwyth University

Abnova Corp

Acobiom

Advanced Marker Discovery SL

AIT Austrian Institute of Technology GmbH

Almac Diagnostics Ltd

ANGLE plc

Armune BioScience Inc

Aurelium BioPharma Inc.

Avant Diagnostics, Inc.

BARD1 Life Sciences Ltd

BioAffinity Technologies, Inc.

Biocept Inc

BioChain Institute Inc

Biodesix Inc

Biological Dynamics, Inc.

BioMark Diagnostics Inc.

BioMarker Strategies LLC

BioNTech AG

BioSystems International

Cancer Genetics Inc

Cancer Research Technology Ltd

Cangen Biotechnologies Inc

CDI Laboratories Inc

Celcuity LLC

Cellanyx Diagnostics, Inc.

CeMines, Inc.

Cepheid

Ceres Nanosciences Inc

Cernostics Inc

ChemImage Corp

Children's Hospital Boston

Clarient Inc

Courtagen Life Sciences Inc

Creatv MicroTech, Inc

DiagnoCure Inc.

EDP Biotech Corporation

Emory University

Enterome Bioscience SA

Epic Sciences Inc

Epigenomics AG

Eventus Diagnostics Inc

Exact Sciences Corp

Exiqon A/S

Exosomics Siena SpA

Fahy Gurteen UK Ltd

Fina Biotech SL

Foundation Medicine Inc

French National Institute of Health and Medical Research

Fujirebio Diagnostics Inc

Gene Express, Inc.

GeneCentric Diagnostics, Inc.

Global Discovery Biosciences Corporation

GlycoZym

Guardant Health Inc

ImmunoCellular Therapeutics Ltd

Insight Genetics Inc

InterGenetics Inc

IV Diagnostics Inc

Janssen Biotech Inc

Louisville Bioscience, Inc.

MDNA Life Sciences Inc

MDxHealth SA

MEDITE Cancer Diagnostics Inc

Memory Dx LLC

Merrimack Pharmaceuticals Inc

Metabolon Inc

Metanomics Health GmbH

MetaStat Inc

Milagen Inc

Nanocytomics LLC

NEOMICS Co Ltd

NovaGray

Novel Bio-spectrum Technologies Inc

Oncimmune (USA) LLC

OncoCyte Corp

Oncolome Diagnostics Inc

Onconome, Inc.

OncoStem Diagnostics Pvt. Ltd

On-Q-ity, Inc.

OPKO Health Inc

Orion Genomics LLC

OTraces Inc.

PeriRx Inc

PleX Diagnostics Inc

Precision Biologics Inc

PreMD Inc

Proplex Technologies LLC

Proteome Sciences Plc

Proteomika

Quest Diagnostics Inc

Research Center Borstel

Roche Diagnostics International Ltd

Rosetta Genomics Ltd

Roswell Park Cancer Institute

Savicell Diagnostic Ltd.

Sengenics International Pte Ltd

Sienna Cancer Diagnostics Ltd

Simon Fraser University

Sividon Diagnostics GmbH

SomaLogic Inc

Southern Illinois University Carbondale

Syndax Pharmaceuticals Inc

Sysmex Corp

The Prince Charles Hospital

Thermo Fisher Scientific Inc

Transgene SA

Treos Bio Inc

Universal Diagnostics SL

University of California San Francisco

University of Chicago

University of Colorado

University of Maryland

University of Queensland

University of South Florida

University of Strathclyde

US Biomarkers Inc

Vanderbilt University

Ventana Medical Systems Inc

Viomics Inc.

VisionGate Inc

Vitatex Inc.

VolitionRX Ltd

Weizmann Institute of Science

XEPTAGEN SpA

Zetiq Technologies Ltd

ZORA Biosciences Oy